203 related articles for article (PubMed ID: 30259774)
1. Optical coherence tomography findings predictive of response to treatment in diabetic macular edema.
Cho YJ; Lee DH; Kim M
J Int Med Res; 2018 Nov; 46(11):4455-4464. PubMed ID: 30259774
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment.
Kaya M; Karahan E; Ozturk T; Kocak N; Kaynak S
Korean J Ophthalmol; 2018 Aug; 32(4):296-302. PubMed ID: 30091308
[TBL] [Abstract][Full Text] [Related]
3. Optical coherence tomographic patterns in diabetic macula edema can predict the effects of intravitreal bevacizumab injection as primary treatment.
Wu PC; Lai CH; Chen CL; Kuo CN
J Ocul Pharmacol Ther; 2012 Feb; 28(1):59-64. PubMed ID: 21992557
[TBL] [Abstract][Full Text] [Related]
4. Association Between Hyperreflective Dots on Spectral-Domain Optical Coherence Tomography in Macular Edema and Response to Treatment.
Hwang HS; Chae JB; Kim JY; Kim DY
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5958-5967. PubMed ID: 29183041
[TBL] [Abstract][Full Text] [Related]
5. Effect of intravitreal bevacizumab based on optical coherence tomography patterns of diabetic macular edema.
Kim M; Lee P; Kim Y; Yu SY; Kwak HW
Ophthalmologica; 2011; 226(3):138-44. PubMed ID: 21822008
[TBL] [Abstract][Full Text] [Related]
6. Visual outcome after intravitreal bevacizumab depends on the optical coherence tomographic patterns of patients with diffuse diabetic macular edema.
Shimura M; Yasuda K; Yasuda M; Nakazawa T
Retina; 2013 Apr; 33(4):740-7. PubMed ID: 23222391
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of serous retinal detachment in branch retinal vein occlusion and response after primary intravitreal bevacizumab injection.
Poon YC; Chen CH; Kuo HK; Chen YJ; Wu PC; Chen YH; Lee JJ
J Ocul Pharmacol Ther; 2013 Apr; 29(3):319-24. PubMed ID: 23145863
[TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomographic evaluation of foveal hard exudates in patients with diabetic maculopathy accompanying macular detachment.
Ota M; Nishijima K; Sakamoto A; Murakami T; Takayama K; Horii T; Yoshimura N
Ophthalmology; 2010 Oct; 117(10):1996-2002. PubMed ID: 20723993
[TBL] [Abstract][Full Text] [Related]
9. Visual outcome after intravitreal triamcinolone acetonide depends on optical coherence tomographic patterns in patients with diffuse diabetic macular edema.
Shimura M; Yasuda K; Nakazawa T; Hirano Y; Sakamoto T; Ogura Y; Shiono T
Retina; 2011 Apr; 31(4):748-54. PubMed ID: 21836404
[TBL] [Abstract][Full Text] [Related]
10. Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection.
Kim MW; Moon H; Yang SJ; Joe SG
Korean J Ophthalmol; 2016 Feb; 30(1):25-31. PubMed ID: 26865800
[TBL] [Abstract][Full Text] [Related]
11. Correlation of fundus autofluorescence with spectral-domain optical coherence tomography and vision in diabetic macular edema.
Chung H; Park B; Shin HJ; Kim HC
Ophthalmology; 2012 May; 119(5):1056-65. PubMed ID: 22342014
[TBL] [Abstract][Full Text] [Related]
12. [Treatment response to Conbercept of different types of diabetic macular edema classified based on optical coherence tomography].
Zhang Y; Yao J; Quan Y; Wang J; Xing Y; Zhou A
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1501-1508. PubMed ID: 34755665
[TBL] [Abstract][Full Text] [Related]
13. CORRELATION OF OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI WITH VISUAL OUTCOMES IN DIFFERENT PATTERNS OF DIABETIC MACULAR EDEMA.
Kang JW; Chung H; Chan Kim H
Retina; 2016 Sep; 36(9):1630-9. PubMed ID: 26900741
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA
Retina; 2007; 27(9):1187-95. PubMed ID: 18046223
[TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomography features during the evolution of serous retinal detachment in patients with diabetic macular edema.
Gaucher D; Sebah C; Erginay A; Haouchine B; Tadayoni R; Gaudric A; Massin P
Am J Ophthalmol; 2008 Feb; 145(2):289-296. PubMed ID: 18054885
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effect of ranibizumab and dexamethasone implant on serous retinal detachment in diabetic macular edema.
Demircan A; Ozkaya A; Alkin Z; Kemer B; Yesilkaya C; Demir G
J Fr Ophtalmol; 2018 Oct; 41(8):733-738. PubMed ID: 30213609
[TBL] [Abstract][Full Text] [Related]
17. Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema.
Gibran SK; Khan K; Jungkim S; Cleary PE
Ophthalmology; 2007 May; 114(5):890-4. PubMed ID: 17467527
[TBL] [Abstract][Full Text] [Related]
18. Early change of central macular thickness after intravitreous triamcinolone or bevacizumab in diabetic macular edema or retinal vein occlusion.
Sonoda Y; Arimura N; Shimura M; Sakamoto T
Retina; 2011 Feb; 31(2):290-7. PubMed ID: 21102366
[TBL] [Abstract][Full Text] [Related]
19. Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema.
Liu Q; Hu Y; Yu H; Yuan L; Hu J; Atik A; Guan M; Li D; Li X; Tang S
Retina; 2015 Feb; 35(2):272-9. PubMed ID: 25105313
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
Soheilian M; Ramezani A; Obudi A; Bijanzadeh B; Salehipour M; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Peyman GA
Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
